Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-arm, Multi-stage, Randomized Phase II/III Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

NCT03879122 is registered in ClinicalTrials.gov with Spanish Oncology Genito-Urinary Group as lead sponsor.

NCT NCT03879122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03879122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-arm, Multi-stage, Randomized Phase II/III Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Lead sponsor
Spanish Oncology Genito-Urinary Group
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 11, 2019
Completion date
December 31, 2024
Enrollment
135 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic hormone-sensitive prostate cancer